Cargando…
A danger of induction of Brugada syndrome during pill-in-the-pocket therapy for paroxysmal atrial fibrillation
Rhythm control therapy by sodium channel blockers is widely performed for the treatment of paroxysmal atrial fibrillation. Here, we present a case of acquired Brugada syndrome by pill-in-the-pocket treatment using pilsicainide. It is important that this therapy should be applied only after confirmin...
Autores principales: | Aizawa, Yoshiyasu, Matsuhashi, Tomohiro, Sato, Toshiaki, Takatsuki, Seiji, Fukuda, Keiichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108709/ https://www.ncbi.nlm.nih.gov/pubmed/21701625 http://dx.doi.org/10.2147/DHPS.S12491 |
Ejemplares similares
-
Comparison of circadian, weekly, and seasonal variations of electrical storms and single events of ventricular fibrillation in patients with Brugada syndrome
por: Aizawa, Yoshiyasu, et al.
Publicado: (2016) -
The Use Of Oral Ranolazine To Convert New Or Paroxysmal Atrial Fibrillation: A Review Of Experience With Implications For Possible "Pill In The Pocket" Approach To Atrial Fibrillation
por: Murdock, David K, et al.
Publicado: (2009) -
“Pill-in-the-Pocket” Treatment of Propafenone Unmasks ECG Brugada Pattern in an Atrial Fibrillation Patient With a Common SCN5A R1193Q Polymorphism
por: Li, Linling, et al.
Publicado: (2019) -
Long‐Term Outcomes of Pulmonary Vein Isolation in Patients With Brugada Syndrome and Paroxysmal Atrial Fibrillation
por: Bisignani, Antonio, et al.
Publicado: (2022) -
Sodium channelopathy with an overlap of Brugada syndrome, paroxysmal atrial fibrillation, and progressive cardiac conduction system dysfunction
por: Bakhit, Yasir, et al.
Publicado: (2023)